The role of cytomegalovirus infection in the pathogenesis of periodontal diseases

Acta Clinica Croatica

Volumn 50, Issue 1, 2011, Pages 61-66

  Beader, Nataša ^a   Ivić Kardum, Marija ^b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Cytomegalovirus; Periodontal diseases etiology

Indexed keywords

BETA INTERFERON; CATHEPSIN; COLLAGEN; COLLAGENASE 3; ELASTIN; GAMMA INTERFERON; GELATINASE B; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; KININ; LAMININ; LEUKEMIA INHIBITORY FACTOR; LEUKOCYTE ELASTASE; MACROPHAGE ELASTASE; OSTEOCLAST DIFFERENTIATION FACTOR; PROSTAGLANDIN E2; PROTEOGLYCAN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; STROMELYSIN; THROMBIN; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ALVEOLAR BONE; B LYMPHOCYTE; BONE DESTRUCTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; COMPLEMENT SYSTEM; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; ENDOTHELIUM CELL; EPSTEIN BARR VIRUS; FIBROBLAST; HUMAN; INFLAMMATION; INNATE IMMUNITY; KERATINOCYTE; LEUKOCYTE; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MAST CELL; MONOCYTE; NEUTROPHIL; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PATHOGENESIS; PERIODONTAL DISEASE; REVIEW; STEM CELL; T LYMPHOCYTE; TH1 CELL; IMMUNOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; VIROLOGY;

CYTOMEGALOVIRUS INFECTIONS; HUMANS; INFLAMMATION; PERIODONTAL DISEASES;

EID: 84855181237     PISSN: 03539466     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Offenbacher S, Barros SP, Beck JD. Rethinking periodontal inflammation. J Periodontol 2008;79:1577-84.
2. Soder PO, Neuerman JH, Jogestrand T, Nowak J, Soder B. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in blood as markers for early atherosclerosis in subjects with chronic periodontitis. J Periodontal Res 2008;44:452-8.
3. King GL. The role of inflammatory cytokines in diabetes and its complications. J Periodontol 2008;79:1527-34.
4. Williams R. Understanding and managing periodontal diseases. A notable past, a promising future. J Periodontol 2008;79:1552-9.
5. Cochran DL. Inflammation and bone loss in periodontal disease. J Periodontol 2008;79:1569-76.
6. Page RC, Schroeder HE. Current status of the host response in chronic marginal periodontitis. J Periodontol 1981;52:477-91.
7. Giannobile WV. Host-response therapeutics for periodontal disease. J Periodontol 2008;79:1592-600.
8. Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T. Cytokines differentially regulate CXCl 10 production by interferon-γ-stimulated or tumor necrosis factor-α-stimulated human gingival fibroblasts. J Periodontal Res 2008;44:225-31.
9. Graves D. Cytokines that promote periodontal tissue destruction. J Periodontol 2008;79:1585-91.
10. Kubota T, Itagaki M, Hoshino C, Nagata M, Morozumi T, Kobayashi T, Takagi R, Yoshie H. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue. J Periodontol 2008;79:166-73.
11. Hofbauer LC, Schoppet M. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular disorders. JAMA 2004;292:490-5.
12. Garlet GP, Cardoso CR, Silava TA, Ferreira BR, Avila-Campos MJ, Cunha FQ, Silva JS. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMP's, RANKL, and their physiological inhibitors. Oral Microbiol Immunol 2006;21:12-20.
13. Lamster IB, Ahlo JK. Analysis of gingival crevicular fluid as applied to the diagnosis of oral and systemic diseases. Ann N Y Acad Sci 2007;1098:216-29.
14. Kinney JS, Ramscier CA, Giannobile WV. Oral fluid-based biomarkers of alveolar bone loss in periodontitis. Ann N Y Acad Sci 2007;1098:230-51.
15. Thaweboon B, Laohapand P, Amornchat C, Matsuyama J, Sato T, Nunez PP, Uematsu H, Hoshino E. Host β-globin gene fragments in crevicular fluid as a biomarker in periodontal health and disease. J Periodontal Res 2010;45:38-44.
16. Beader N, Škrablin -Kučić S, Mihaljevi ć S, Veir Z. Uloga IgG avidnosti u dijagnostici citomegalovirusne infekcije tijekom trudnoće. Gynaecol Perinatol 2009;18:151-5.
17. Schleiss MR. The role of placenta in the pathogenesis of congenital cytomegalovirus infection: is the benefit of cytomegalovirus immune globulin for the newborn mediated through improved placental health and function? Clin Infect Dis 2006;43:1001-3.
18. Jaskoll T, Abichaker G, Jangaard N, Brin -gas P Jr, Melnick M. Cytomegalovirus inhibition of embryonic mouse tooth development: a model of the human amelogenesis imperfecta phenocopy. Arch Oral Biol 2008;53:405-15.
19. Ting M, Contreras A, Slots J. Herpesviruses in localized juvenile periodontitis. J Periodontal Res 2000;35:17-25.
20. Hangel H, Brune W, Koszinowski UH. Immune evasion by cytomegalovirus - survival strategies of a highly adapted opportunist. Trends Microbiol 1998;6:190-7.
21. Hummel M, Abecassis MM. A model for reactivation of CMV from latency. J Clin Virol 2002;25:S123-36.
22. Cao Z, Li C. Xiang J. Effect of matrix metalloproteinase-1 promoter genotype on interleukin-1-beta-induced matrix metalloproteinase-1 production in human periodontal ligament cells. J Periodontal Res 2010;45:109-15.
23. Nasatzky E, Rubinstein Y, Goultschin J, Schwartz Z. The role of matrix metalloproteinases in the progression of periodontitis, and the use of specific in-hibitors to these enzymes in the treatment of the periodontal disease. Refuat Hapeh Vehashinayim 2003;20:38-45.
24. Botero JE, Contreras A, Parra B. Effects of cytomegalovirus infection on the mRNA expression of collagens and matrix metalloproteinases in gingival fibroblasts. J Periodontal Res 2008;43:649-57.
25. Contreras A, Slots J. Herpesviruses in human periodontal disease. J Periodontal Res 2000;35:3-16.